MarginsXMarginsX
Home › Markets › Health Care › OGI

Organigram Global Inc. Common Shares (OGI)

OGI trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$0.7240
-12.62% on the day
Market cap
$102.2M
Micro cap
Revenue · 2025
$181.8M
+62.2% on 2024
Net income · 2025
-$17.4M
-9.6% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC filing XBRL, 40-F (ifrs-full:Revenue), fiscal year ended 2025-09-30, https://www.sec.gov/Archives/edgar/data/1620737/000162828025057233/0001628280-25-057233-index.htm. Net income: SEC 40-F (ifrs-full:ProfitLoss), fiscal year ended 2025-09-30. Converted from CAD at 1.4258 per USD (today's ECB or Federal Reserve reference rate).

Profile

FieldValue
TickerOGI on Nasdaq
SectorHealth Care
IndustryBiotechnology: Pharmaceutical Preparations
CountryCanada
IPO yearNot reported by the screener
SEC CIK0001620737
SEC industry codePharmaceutical Preparations
Incorporated inCanada
Canadian listingTSX: OGI

Financials · 2025

LineValue
Revenue$181.8M
Net income-$17.4M
Operating income-$10.7M
Net margin-9.6%
Operating margin-5.9%
Revenue growth+62.2%
Cash$58.6M
Total assets$394.3M
P/E (computed)Net income was not positive
P/S (computed)0.6×

Reported in CAD; shown in US dollars.

Warning signs

Cash runway
132.1 months
83.6M CAD cash at September 30, 2025
Share count, 1 year
+23.8%
2024-09-30 to 2025-09-30
Going-concern doubt
No
40-F filed December 16, 2025
Insider net buying, 12 months
$0
Through September 30, 2026
SignFindingSource
Going concernNo going-concern finding.40-F 2025-12-16
Cash and burn83.6M CAD cash; operating cash flow -1.9M CAD a quarter.Report 2025-09-30
Shares outstanding134,461,029 (2025-09-30); 108,585,492 a year earlier. the newest SEC cover-page count is from 2025-09-30; shares issued since then are not in these figures.Cover page 2025-09-30
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 0 424B5 takedownsNone on EDGAR
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorPKF O'Connor Davies, LLP, New York, New York, United StatesPCAOB Form AP 2026-01-05
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $0, sold $0 on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Annual results

Fiscal yearRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
FY 2025
2025-09-30
259.2M CAD-24.8M CAD-7.6M CAD83.6M CAD25K CAD259.2M CAD40-F 2025-12-16
FY 2025
2024-09-30
159.8M CAD-45.4M CAD3.9M CADNot filed25K CAD159.8M CAD40-F 2024-12-18
FY 2022
2022-08-31
145.8M CAD-14.3M CAD-36.2M CADNot filed235K CAD145.8M CAD40-F 2023-12-19
FY 2021
2021-08-31
79.2M CAD-130.7M CAD-28.6M CADNot filed310K CAD79.2M CAD40-F 2022-11-29
FY 2020
2020-08-31
86.8M CAD-136.2M CAD-45.1M CADNot filed115.3M CAD86.8M CAD40-F 2021-11-23
FY 2019
2019-08-31
80.4M CAD-9.5M CAD-35.1M CADNot filed49.6M CAD80.4M CAD40-F 2020-11-30
FY 2018
2018-08-31
12.4M CAD20.5M CAD-12.7M CADNot filed3.3M CAD12.4M CAD40-F/A 2019-12-27

From SEC XBRL company facts (annual reports only: 20-F or 40-F). Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months). Amounts in CAD.

Key SEC documents

DocumentFormFiled
Latest annual report40-F2025-12-16
Latest quarterly / interim6-K2026-11-16

Source: SEC EDGAR submissions feed, 324 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week-5.5%
1 month-9.8%
3 months-34.2%
Year to date-50.7%
1 year-46.2%
From 52-week high-60.7%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Biotechnology: Pharmaceutical Preparations

TickerCompanyPriceDayMarket cap
CUECue Biopharma Inc.$14.10-12.53%$102.4M
UNCYUnicycive Therapeutics Inc.$3.70+4.23%$103.1M
ORGOOrganogenesis Holdings Inc.$0.8031-0.86%$104.2M
DERMJourney Medical Corporation$3.70-14.55%$104.5M
CLLSCellectis S.A.$1.04-11.86%$104.5M
ADAGAdagene Inc.$1.60-6.43%$105.7M
BGMBGM Group Ltd.$8.01+1.71%$107.0M
FHTXFoghorn Therapeutics Inc.$1.79-13.53%$107.3M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier